Table 2.
Preoperative management of patients with diabetes - Regarding the use of insulin
| Insulin type | Time of onset | Duration | Peak effect |
|---|---|---|---|
| Rapid-acting | |||
| Lispro | 10-30 min | 3-5 h | 30-60 min |
| Aspart | 10-30 min | 3-5 h | 30-60 min |
| Glulisine | 10-30 min | 3-5 h | 2 h |
| Short-acting | |||
| Regular human insulin | 30-60 min | 5-12 h | 1.5-2 h |
| Intermediate-acting | |||
| NPH, Lente | 1-2 h | 10-20 h | 4-8 h |
| Long-acting | |||
| Ultralente | 2-4 h | 16-24 h | 8-20 h |
| Glargine | Up to 6 h | Up to 24 h | No peak |
| Detemir | 2-4 h | 20 h | No peak |
| Degludec | 0.5-1.5 h | Up to 48 h | No peak |
| Gla-300 | Up to 6 h | Up to 36 h | No peak |
Source: McKenna.[25] NPH – Neutral protamine Hagedorn